11-75605876-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000304771.8(MAP6):c.1248G>A(p.Pro416=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00541 in 1,614,140 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 38 hom. )
Consequence
MAP6
ENST00000304771.8 synonymous
ENST00000304771.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.737
Genes affected
MAP6 (HGNC:6868): (microtubule associated protein 6) This gene encodes a microtubule-associated protein. The encoded protein is a calmodulin-binding and calmodulin-regulated protein that is involved in microtubule stabilization. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 11-75605876-C-T is Benign according to our data. Variant chr11-75605876-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 782216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 38 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP6 | NM_033063.2 | c.1248G>A | p.Pro416= | synonymous_variant | 3/4 | ENST00000304771.8 | NP_149052.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP6 | ENST00000304771.8 | c.1248G>A | p.Pro416= | synonymous_variant | 3/4 | 1 | NM_033063.2 | ENSP00000307093 | A2 | |
MAP6 | ENST00000434603.2 | c.1248G>A | p.Pro416= | synonymous_variant | 3/3 | 1 | ENSP00000415108 | P2 | ||
MAP6 | ENST00000526740.3 | c.261G>A | p.Pro87= | synonymous_variant | 3/4 | 5 | ENSP00000434278 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00371 AC: 564AN: 152136Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
564
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00471 AC: 1177AN: 249826Hom.: 9 AF XY: 0.00474 AC XY: 641AN XY: 135174
GnomAD3 exomes
AF:
AC:
1177
AN:
249826
Hom.:
AF XY:
AC XY:
641
AN XY:
135174
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00559 AC: 8172AN: 1461886Hom.: 38 Cov.: 35 AF XY: 0.00557 AC XY: 4054AN XY: 727242
GnomAD4 exome
AF:
AC:
8172
AN:
1461886
Hom.:
Cov.:
35
AF XY:
AC XY:
4054
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00370 AC: 564AN: 152254Hom.: 1 Cov.: 32 AF XY: 0.00348 AC XY: 259AN XY: 74430
GnomAD4 genome
AF:
AC:
564
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
259
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | MAP6: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at